Source: Seeking Alpha

CRISPR: CRISPR Therapeutics set to snap six straight sessions of losses

Read full article »
CRISPR's Competitors | CRISPR's News | CRISPR's Financials
Stay up-to-date with the latest news on CRISPR
Annual Revenue
$25-100M
Employees
250-500
Samarth Kulkarni's photo - CEO of CRISPR

CEO

Samarth Kulkarni

CEO Approval Rating

94/100

Read more
Stay up-to-date with the latest news on CRISPR